JOHN GOMEZ: Open Payments
NPI 1477078095 · MIDDLETOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$799 in 37 payments from 9 companies in 2025. Trend: 2023 $702 · 2024 $980 · 2025 $799
Food & beverage: $799
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 22 | $466 |
| Lundbeck LLC | 3 | $68 |
| Neurocrine BioSciences, Inc. | 3 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| ABBVIE INC. | 2 | $40 |
| Janssen Pharmaceuticals, Inc | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Alkermes, Inc. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
Products named: COBENFY, REXULTI, INGREZZA, CAPLYTA, VRAYLAR, SPRAVATO, ARISTADA, FANAPT.
Industry payments across NY — which companies pay providers there.
